There is also evidence that SOCS3-mediated insulin resistance is involved in the upregulation of mediators (e.g. tumor necrosis factor-α (TNF-α), Interleukin 6 (IL6)) signaling pathways. The gene discussed is IL6; the disease is Insulin resistance.